115279-73-7

Basic information

• Product Name: ASISCHEM D50964
• Synonyms: ASISCHEM D50964;1-(4-AMINOPHENYL)CYCLOPENTANECARBONITRILE;1-(4-aminophenyl)cyclopentanecarbonitrile(SALTDATA: FREE);1-(4-aminophenyl)cyclopentane-1-carbonitrile
• CAS NO: 115279-73-7
• Molecular Formula: C₁₂H₁₄N₂
• Molecular Weight: 186.25
• Mol File: 115279-73-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 375°C at 760 mmHg
• Flash Point: 180.6°C
• Appearance: /
• Density: 1.11g/cm³
• Vapor Pressure: 8.01E-06mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 5.05±0.10(Predicted)
• CAS DataBase Reference: ASISCHEM D50964(CAS DataBase Reference)
• NIST Chemistry Reference: ASISCHEM D50964(115279-73-7)
• EPA Substance Registry System: ASISCHEM D50964(115279-73-7)

Safety Data

• Hazardous Substances Data: 115279-73-7(Hazardous Substances Data)

Usage

General Description

Information about the chemical "ASISCHEM D50964" is extremely limited online and it's not listed in common chemical databases or scientific literature. It's possible that it could be a catalogue number, product code or internal reference number used by a specific organization. As such, it would be best to contact the relevant manufacturer or supplier directly for accurate information. It's also crucial to handle any unknown chemicals safely and responsibly, while following all relevant safety regulations and guidelines.

InChI:InChI=1/C12H14N2/c13-9-12(7-1-2-8-12)10-3-5-11(14)6-4-10/h3-6H,1-2,7-8,14H2

Upstream product

• 91392-33-5 1-(4-nitrophenyl)cyclopentane-1-carbonitrile 
• 555-21-5 4-Nitrophenylacetonitrile 
• 140-29-4 phenylacetonitrile 
• 77-57-6 1-phenyl-1-cyclopentanecarbonitrile 

Downstream Products

• 133825-88-4 1-<4-(dimethylamino)phenyl>cyclopenatnecarbonitrile 
• 1275609-09-0 N-[4-(1-cyanocyclopentyl)phenyl][2-[(4-pyridylmethyl)amino](3-pyridyl)]carboxamide 
• 1158560-99-6 N-[4-(1-cyanocyclopentyl)phenyl][2-chloro(3-pyridyl)]carboxamide 
• 1067189-50-7 3,4-dimethoxy-N-[4-(1-methylcarbamoyl-cyclopentyl)-phenyl]-benzamide 
• 1067192-35-1 1-[4-(3,4-dimethoxy-benzoylamino)-phenyl]-cyclopentanecarboxylic acid 
• 1067189-49-4 1-[4-(3,4-dimethoxy-benzoylamino)-phenyl]-cyclopentanecarboxylic acid methyl ester 
• 1067189-54-1 3,4-dimethoxy-N-{4-[1-(5-methyl-[1,2,4]oxadiazol-3-yl)-cyclopentyl]-phenyl}-benzamide 
• 1067189-51-8 N-[4-(1-cyano-cyclopentyl)-phenyl]-4-hydroxy-3-methoxy-benzamide 
• 1030658-42-4 benzo[1,3]dioxole-5-carboxylic acid [4-(1-cyano-cyclopentyl)-phenyl]-amide 
• 1067189-46-1 N-[4-(1-cyano-cyclopentyl)-phenyl]-4-dimethylamino-benzamide 
• 91640-63-0 1-(p-aminophenyl)cyclopentanecarboxylic acid 
• 1030545-24-4 2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid [4-(1-cyano-cyclopentyl)-phenyl]-amide 

Relevant articles and documents

Industrial Cunninghamia lanceolata carbon supported FeO(OH) nanoparticles-catalyzed hydrogenation of nitroarenes

The development of green and efficient methods for hydrogenation of nitroarenes is still highly demanding in organic synthesis. Herein, we report an industrial Cunninghamia lanceolata carbon supported FeO(OH) nanoparticles process for the synthesis of aryl amines with good yields via hydrogenation of nitroarenes. Nine key anti-cancer drug intermediates were successfully achieved with protocol. And Osimertinib intermediate 4m can be smoothly synthesized at a 2.67 kg-scale with >99.5% HPLC purity. This protocol features cheap carbon source, highly catalytic activity, simple operation, kilogram-scalable and recyclable catalysts (eight times without observable losing activity).

Apatinib preparation method

The present invention relates to an apatinib preparation method, wherein specifically an organic solvent is selected to perform refining crystallization to obtain the apatinib. The method of the present invention has advantages of simple operation and low cost, and is suitable for large-scale production.

NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE

The present invention provides new compounds of formula I, wherein Q, R1, R2, R4, R5, R6, Xi, R7, R8, M and G1 nare defined as in formula I; invention compounds are modulators of follicle-stimulating hormone - ("FSH") which are useful for male and female contraception as well as other disorders modulated by FSH receptor.